News

Conference

ASRM 2025 – The American Society for Reproductive Medicine

We are pleased to announce that Kitazato Corporation will exhibit at ASRM 2025: The American Society for Reproductive Medicine, where we will showcase our latest products and present our research on vitrification solutions.

In the oral presentation, our representative will introduce preclinical research results validating the effectiveness of a novel one-step protocol for oocyte vitrification.

During the exhibition, we will also host hands-on workshops using our new Ultra-Fast™ products, along with in-booth lectures by leading embryologists.

We sincerely look forward to welcoming you to our booth.
 


Conference Details


Dates: October 25–29, 2025

Venue: Henry B. Gonzalez Convention Center, San Antonio, TX, USA

 


ASRM 2025 Oral Presentation


Date & Time: October 28, 2025 | 11:51 AM – 12:02 PM

Room: 216 AB (Meeting Level, Henry B. Gonzalez Convention Center)

Abstract Number: O-121

Session:

Oral Abstract Session – Pre-Clinical & Basic Research (1 of 2)

Title:

Preclinical Validation of a Novel One-Step Protocol for Oocyte Vitrification

 


Exhibition Booth


Dates: October 25–29, 2025

Location: Henry B. Gonzalez Convention Center, Booth No. 835

 


In-booth events 


Location: Booth No. 835 (Kitazato Corporation Booth)

Dates(1): October 27, 2025 | 10:00 AM

Speaker:

Alison Campbell
Chief Scientific Officer, Care Fertility

Topic: Pushing the limits: Ultra-Fast Warming Experience by Care Fertility

 

Dates(2): October 28, 2025 | 10:00 AM

Speaker:

Kathleen Miller
Chief Scientific Officer, Innovation Fertility

Topic: Oil Change: Fine-Tuning Embryo Development

Back to News List

Being ISO certified company,
we ensure high-quality product and also be environmentally-friendly.

  • MD 548540 / ISO 13485

    MD 548540 / ISO 13485

  • FM 597440 / ISO 9001

    FM 597440 / ISO 9001

    Manufacture of physical instruments

  • FM 597440 / ISO 9001

    EMS 745661 / ISO 14001

    ※Administrative department in
    the manufacturing of infertility
    treatment devices.